SUSPENDED

An Adaptive Prenatal Intervention to Increase Childhood Vaccinations

Conditions

Quick Navigation

Study Overview

This clinical trial focuses on testing the efficacy of different digital interventions to promote re-engagement in cancer-related long-term follow-up care for adolescent and young adult (AYA) survivors of childhood cancer.

Description

This study will test whether proactively connecting expectant parents with factual vaccination information during pregnancy can build confidence in vaccinations and lead to timely vaccinations during pregnancy and once their child is born.

Official Title

An Adaptive Prenatal Intervention to Increase Childhood Vaccinations

Quick Facts

Study Start:2024-04-27

Study Completion:2026-08-31

Study Type:Not specified

Phase:Not Applicable

Enrollment:Not specified

Status:SUSPENDED

Study ID

NCT05795855

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Ages Eligible for Study:Not specified

Sexes Eligible for Study:FEMALE

Accepts Healthy Volunteers:Yes

Standard Ages:CHILD, ADULT, OLDER_ADULT

Inclusion Criteria	Exclusion Criteria
* Nulliparous individuals (no prior live birth) * Singleton pregnancy (excludes twins, triplets, etc.) * No known fetal congenital malformations or genetic abnormalities * Not at known risk for preterm birth * In late second trimester during study recruitment period * Receive prenatal care at one of the study practices * Eligible to receive adaptive components of ADEPT (vaccine-hesitant after provider recommendation) * At least 18 years of age * Provide informed consent * Agree to participate in surveys and in-depth interview * Agree for child's vaccination outcomes to be extracted from the North Carolina Immunization Registry (NCIR) * Plan to stay in North Carolina for at least 3 months after delivery	* none

Inclusion Criteria

Exclusion Criteria

* Nulliparous individuals (no prior live birth)
* Singleton pregnancy (excludes twins, triplets, etc.)
* No known fetal congenital malformations or genetic abnormalities
* Not at known risk for preterm birth
* In late second trimester during study recruitment period
* Receive prenatal care at one of the study practices
* Eligible to receive adaptive components of ADEPT (vaccine-hesitant after provider recommendation)
* At least 18 years of age
* Provide informed consent
* Agree to participate in surveys and in-depth interview
* Agree for child's vaccination outcomes to be extracted from the North Carolina Immunization Registry (NCIR)
* Plan to stay in North Carolina for at least 3 months after delivery

* none

Contacts and Locations

Principal Investigator

Lavanya Vasudevan, PhD, MPH

PRINCIPAL_INVESTIGATOR

Emory University

Study Locations (Sites)

Duke Health System

Durham, North Carolina, 27710

United States

Collaborators and Investigators

Sponsor: Emory University

Lavanya Vasudevan, PhD, MPH, PRINCIPAL_INVESTIGATOR, Emory University

Study Record Dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Registration Dates

Study Start Date2024-04-27

Study Completion Date2026-08-31

Study Record Updates

Study Start Date2024-04-27

Study Completion Date2026-08-31

Terms related to this study

Keywords Provided by Researchers

Vaccine hesitancy

Additional Relevant MeSH Terms

Vaccination Refusal